Design to Delivery: POMs in Future Transmembrane Transport

The forthcoming study will examine whether tiny metal-oxygen coordination compounds called polyoxometalates (POMs) can serve as molecular couriers that transport medicines and other biomolecules across cellular membranes. POMs are known for their structural flexibility and rich chemistry, yet their potential to penetrate the lipid barrier enclosing every cell has so far received little systematic attention. Preliminary observations indicate that certain POM structures may escort positively charged peptides through membranes without causing lysis. Three research phases have been scheduled. Design and synthesis A diverse library of POMs will be prepared by altering metal centres, overall geometry (spherical Keggin, planar Anderson and other archetypes) and net charge. Stability assessment Each cluster will be exposed to blood-like buffers and artificial lipid vesicles to determine whether the intended structure and charge persist under physiological conditions. Nuclear magnetic resonance (NMR) spectroscopy and electrospray-ionisation mass spectrometry (ESI-MS) will be employed. Transport testing The most robust POMs will be evaluated as carriers for two categories of cargo: (i) short, cationic peptides relevant to drug delivery and (ii) impermeable or poorly permeable therapeutics such as selected antibiotics and an anti-cancer kinase inhibitor. Experiments will be conducted in model membranes, bacterial strains and cancer cell lines. Should the planned work succeed, a foundation will be laid for a new class of inexpensive, highly stable drug-delivery systems. Unlike liposomes, which can disintegrate rapidly, POMs remain shelf-stable as dry powders and dissolve easily in water, properties that could facilitate large-scale medical deployment. A clearer understanding of their superchaotropic surface, which favours contacts with both water and lipids, may further inspire advanced membranes for energy storage, green solvents and other technologies. By clarifying the factors that permit inorganic clusters to cross biological borders, the project aims to translate fundamental chemistry into future therapeutic applications.